Pooled analysis of uPA and PAI-1 for prognosis in primary breast cancer patients. EORTC Receptor and Biomarker Study Group

Int J Biol Markers. Jan-Mar 2000;15(1):70-2.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / surgery
  • Female
  • Humans
  • Laboratories / standards*
  • Patient Selection
  • Plasminogen Activator Inhibitor 1 / analysis*
  • Prognosis
  • Quality Assurance, Health Care
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Urokinase-Type Plasminogen Activator / analysis*

Substances

  • Plasminogen Activator Inhibitor 1
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Urokinase-Type Plasminogen Activator